Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
Farmers Insurance
Deloitte
Colorcon
Citi
Merck
Chubb
Baxter
Dow

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 3,839,315

« Back to Dashboard

Summary for Patent: 3,839,315
Title: NOVEL PEPTIDES HAVING CHOLECYSTOKININ ACTIVITY AND INTERMEDIATES THEREFOR
Abstract:Novel peptide amides of the general formula R-Met-Gly-Trp-Met-Asp-Phe-NH.sub.2 wherein R represents L-aspartyl-O-sulfate-L-tyrosyl, L-aspartyl-L-arginyl-L-aspartyl-O-sulfate-L-tyrosyl, or isoleucyl-L-seryl-L-aspartyl-L-arginyl-L-aspartyl-O-sulfate-L-tyrosyl, and intermediates in the production thereof. The peptide amides of this invention as well as the pharmaceutically acceptable salts thereof have been found to possess cholecystokinin activity.
Inventor(s): Ondetti; Miguel A. (North Brunswick, NJ), Pluscec; Josip (East Brunswick, NJ), Sheehan; John T. (Middlesex, NJ), Jorpes; Johan E. (Stockholm, SW), Mutt; Viktor (Farsta, SW)
Assignee: E. R. Squibb & Sons, Inc. (New York, NY)
Application Number:04/726,558
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 3,839,315

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 3,839,315

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 945145 ➤ Try a Free Trial
Canada 987666 ➤ Try a Free Trial
Switzerland 517702 ➤ Try a Free Trial
Germany 1922185 ➤ Try a Free Trial
Denmark 132074 ➤ Try a Free Trial
France 2007810 ➤ Try a Free Trial
United Kingdom 1278681 ➤ Try a Free Trial
United Kingdom 1278682 ➤ Try a Free Trial
Japan S4813114 ➤ Try a Free Trial
Sweden 372007 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Accenture
Fuji
QuintilesIMS
Citi
Chubb
Boehringer Ingelheim
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot